2026 Meningococcal disease strategy: epidemiology, Factor H binding protein biology, clinical competition, recent deals, unmet need and market attractiveness.

2026 Pertussis strategy: epidemiology, Pertussis toxin biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…

2026 Rubella strategy: epidemiology, Rubella E1 protein biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…

2026 Mumps strategy: epidemiology, Mumps HN protein biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…

2026 Measles strategy: epidemiology, Measles H protein biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…

2026 Rabies strategy: epidemiology, Rabies G protein biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…

2026 Yellow fever strategy: epidemiology, YFV E protein biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…

2026 Tick-borne encephalitis strategy: epidemiology, TBEV E protein biology, clinical competition, recent deals, unmet need and market attractiveness.

2026 Japanese encephalitis strategy: epidemiology, JEV E protein biology, clinical competition, recent deals, unmet need and market attractiveness.

2026 West Nile virus infection strategy: epidemiology, West Nile E protein biology, clinical competition, recent deals, unmet need and market attractiveness.

2026 Hantavirus pulmonary syndrome strategy: epidemiology, Hantavirus Gn biology, clinical competition, recent deals, unmet need and market attractiveness.

2026 Crimean-Congo hemorrhagic fever strategy: epidemiology, CCHFV glycoprotein biology, clinical competition, recent deals, unmet need and market attractiveness.